Hematology & Oncology in Newport Beach, CA
14 verified hematology & oncology doctors in Newport Beach.
Hematologist-oncologists treat blood disorders and cancers, coordinating chemotherapy and blood-related care.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Andrea Stebel, MD
Hematology & Oncology
CMS Open Payments· $79,700 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$79,700
Total received
157
Transactions
5
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 89th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Andrea Stebel do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Misagh Karimi, MD
Hematology & Oncology
CMS Open Payments· $104,265 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$104,265
Total received
101
Transactions
12
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Misagh Karimi do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Greg Angstreich, MD
Hematology & Oncology
CMS Open Payments· $152.45 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$152.45
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 51th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Greg Angstreich do not imply any wrongdoing. Many are meals, education, or research support.
Dr. George Semeniuk, MD
Hematology & Oncology
CMS Open Payments· $100,431 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$100,431
Total received
22
Transactions
5
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to George Semeniuk do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Louis Vandermolen, MD
Hematology & Oncology
CMS Open Payments· $97.10 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$97.10
Total received
5
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Louis Vandermolen do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Wade Smith, MD
Hematology & Oncology
CMS Open Payments· $50,700 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$50,700
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 87th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Wade Smith do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Robert Dillman, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Robert Carroll, MD
Hematology & Oncology
CMS Open Payments· $470.37 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$470.37
Total received
12
Transactions
11
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 61th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Robert Carroll do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Neil Barth, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Tingting Tan, MD
Hematology & Oncology
CMS Open Payments· $14.42 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$14.42
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 38th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Tingting Tan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Simon Khagi, MD
Hematology & Oncology
CMS Open Payments· $17,121 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$17,121
Total received
31
Transactions
7
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Simon Khagi do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Sara Beygi, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. David Benjamin, MD
Hematology & Oncology
CMS Open Payments· $27,371 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$27,371
Total received
23
Transactions
7
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to David Benjamin do not imply any wrongdoing. Many are meals, education, or research support.